HIV Infections - Mortality
Research News and Information

Sunday, November 22, 2009

Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.

30 Oct 2009 BACKGROUND: Achieving virologic suppression is a clear therapeutic goal for patients receiving combination antiretroviral therapy (cART). However, the effects of immunologic responses, whether measured as CD4 count changes from baseline or CD4 ... Read more...

The association between food insecurity and mortality among HIV-infected individuals on HAART.

30 Oct 2009 BACKGROUND: Food insecurity is increasingly recognized as a barrier to optimal treatment outcomes, but there is little data on this issue. We assessed associations between food insecurity and mortality among HIV-infected antiretroviral ... Read more...

Interleukin-2 therapy in patients with HIV infection.

13 Oct 2009 BACKGROUND: Used in combination with antiretroviral therapy, subcutaneous recombinant interleukin-2 raises CD4+ cell counts more than does antiretroviral therapy alone. The clinical implication of these increases is not known. METHODS: We conducted ... Read more...

Latest indexed articles for 'HIV Infections - Mortality'

These are the very latest articles for this heading:

• Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression. 30 Oct 2009
• The association between food insecurity and mortality among HIV-infected individuals on HAART. 30 Oct 2009
• Interleukin-2 therapy in patients with HIV infection. 13 Oct 2009
• HIV-specific health care utilization and mortality among tuberculosis/HIV coinfected persons. 29 Sep 2009
• Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs. 13 Sep 2009
• Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort. 13 Sep 2009
• Global patterns of mortality in young people: a systematic analysis of population health data. 10 Sep 2009
• Young people: not as healthy as they seem. 10 Sep 2009
• Zimbabwe queues. 30 Aug 2009
• High mortality risk among individuals assumed to be TB-negative can be predicted using a simple test. 30 Aug 2009
• CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia. 30 Aug 2009
• Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia. 30 Aug 2009
• Expanding antiretroviral options in resource-limited settings--a cost-effectiveness analysis. 30 Aug 2009
• Beyond HAART: scientists and activists need to work together. 22 Aug 2009
• Early versus deferred antiretroviral therapy for HIV. 18 Aug 2009
• Early versus deferred antiretroviral therapy for HIV. 18 Aug 2009
• Early versus deferred antiretroviral therapy for HIV. 18 Aug 2009
• 5-year survival of patients with AIDS receiving antiretroviral therapy in Haiti. 18 Aug 2009
• Early versus deferred antiretroviral therapy for HIV. 18 Aug 2009
• Five-year outcomes of the China National Free Antiretroviral Treatment Program. 16 Aug 2009

See a longer list of these articles.

Technical information about 'HIV Infections'

Definition: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).

Descriptor UI: D015658

Alternative terms: HIV Infections; HIV Infection; Infection, HIV; Infections, HIV; HTLV-III-LAV Infections; HTLV III LAV Infections; HTLV-III-LAV Infection; Infection, HTLV-III-LAV; Infections, HTLV-III-LAV; T-Lymphotropic Virus Type III Infections, Human; T Lymphotropic Virus Type III Infections, Human; HTLV-III Infections; HTLV III Infections; HTLV-III Infection; Infection, HTLV-III; Infections, HTLV-III;

Related Mesh Headings: Lymphoma, AIDS-Related;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; transmission; urine; veterinary; ultrasonography; virology;

Tree Number: C02.782.815.616.400; C02.800.801.400; C20.673.480;

Online Note: use ACQUIRED IMMUNODEFICIENCY SYNDROME to search HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION 1989; HIV INFECTION 1988-89; HTLV-III INFECTION & HTLV-III LAV INFECTION 1987-89

History Note: 90; T-LYMPHOTROPIC VIRUS TYPE III INFECTION, HUMAN was HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION see ACQUIRED IMMUNODEFICIENCY SYNDROME 1989; HIV INFECTION was see ACQUIRED IMMUNODEFICIENCY SYNDROME 1988-89; HTLV-III INFECTION & HTLV-III-LAV INFECTION were see ACQUIRED IMMUNODEFICIENCY SYNDROME 1987-89

Technical Notes: caused by a lentivirus; GEN or unspecified; coord IM with HIV-1 (IM) or HIV-2 (IM); note specific indentions under HIV INFECTIONS; DF: HIV INFECT